Ambeed.cn

首页 / / / / H-89 2HCl

H-89 2HCl {[allProObj[0].p_purity_real_show]}

货号:A171227 同义名: H-89 (hydrochloride); Protein Kinase Inhibitor H-89

H-89 2HCl是一种高效且选择性的蛋白激酶A(PKA)抑制剂,IC50为48 nM,对PKG、PKC和酪蛋白激酶的抑制作用较弱。

H-89 2HCl 化学结构 CAS号:130964-39-5
H-89 2HCl 化学结构
CAS号:130964-39-5
H-89 2HCl 3D分子结构
CAS号:130964-39-5
H-89 2HCl 化学结构 CAS号:130964-39-5
H-89 2HCl 3D分子结构 CAS号:130964-39-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

H-89 2HCl 纯度/质量文件 产品仅供科研

货号:A171227 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 PKC PKCα PKCβ PKCγ PKCδ PKCε PKCζ PKCη PKCθ 其他靶点 纯度
Daphnetin +

PKC, IC50: 25.01 μM

EGFR,PKA 95%
Dequalinium Chloride 99%+
Quercetin Src,Sirtuin 95%
Myricetrin 96%
Go 6983 +++

PKCα, IC50: 7 nM

+++

PKCβ, IC50: 7 nM

+++

PKCγ, IC50: 6 nM

+++

PKCδ, IC50: 10 nM

++

PKCζ, IC50: 60 nM

99%+
Go6976 +++

PKC, IC50: 7.9 nM

++++

PKCα, IC50: 2.3 nM

+++

PKCβ1, IC50: 6.2 nM

FLT3 99%+
Bisindolylmaleimide I +++

PKCα, IC50: 20 nM

+++

PKCβ2, IC50: 16 nM

PKCβ1, IC50: 17 nM

+++

PKCγ, IC50: 20 nM

99%+
Lawsone methyl ether 99%
Sotrastaurin ++++

PKCα, Ki: 0.95 nM

++++

PKCβ1, Ki: 0.64 nM

++++

PKCδ, Ki: 2.1 nM

++++

PKCε, Ki: 3.2 nM

++++

PKCη, Ki: 1.8 nM

++++

PKCθ, Ki: 0.22 nM

99%+
Enzastaurin ++

PKCα, IC50: 39 nM

+++

PKCβ, IC50: 6 nM

+

PKCγ, IC50: 83 nM

+

PKCε, IC50: 110 nM

98%
Midostaurin ++

PKCα, IC50: 22 nM

++

PKCβ2, IC50: 31 nM

PKCβ1, IC50: 30 nM

++

PKCγ, IC50: 24 nM

+

PKCδ, IC50: 330 nM

+

PKCε, IC50: 1.25 μM

+

PKCη, IC50: 160 nM

99%
Ro 31-8220 mesylate ++++

PKCα, IC50: 5 nM

+++

PKCβ2, IC50: 14 nM

PKCβ1, IC50: 24 nM

++

PKCγ, IC50: 27 nM

++

PKCε, IC50: 24 nM

99%+
Staurosporine ++++

PKCα, IC50: 2 nM

++++

PKCγ, IC50: 5 nM

+++

PKCδ, IC50: 20 nM

++

PKCε, IC50: 73 nM

++++

PKCη, IC50: 4 nM

99%+
Ruboxistaurin HCl +

PKCα, IC50: 0.36 μM

++++

PKCβ2, IC50: 5.9 nM

PKCβ1, IC50: 4.7 nM

+

PKCγ, IC50: 0.3 μM

+

PKCδ, IC50: 0.25 μM

++

PKCη, IC50: 0.052 μM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。
产品名称 PKA 其他靶点 纯度
Daphnetin +

PKA, IC50: 9.33 μM

EGFR,PKC 95%
AT13148 ++++

PKA, IC50: 3 nM

95%
A-674563 HCl +++

PKA, Ki: 16 nM

99%
H-89 2HCl ++

PKA, Ki: 48 nM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。
产品名称 ALK1 ALK2 ALK3 ALK4 ALK6 Smad3 TGF-β TGFβRI/ALK5 TGFβRII 其他靶点 纯度
LDN193189 ++++

ALK1, IC50: 0.8 nM

++++

ALK2, IC50: 0.8 nM

+++

ALK3, IC50: 5.3 nM

+++

ALK6, IC50: 16.7 nM

99%+
LDN-212854 ++++

ALK1, IC50: 2.4 nM

++++

ALK2, IC50: 1.3 nM

+

ALK3, IC50: 85.8 nM

+

ALK4, IC50: 2133 nM

+

ALK5, IC50: 9276 nM

99%+
ML347 ++

ALK1, IC50: 46 nM

++

ALK2, IC50: 32 nM

98%
K02288 ++++

ALK1, IC50: 1.8 nM

++++

ALK2, IC50: 1.1 nM

++

ALK3, IC50: 34.4 nM

+++

ALK6, IC50: 6.4 nM

99%+
LDN-193189 2HCl ++++

ALK1, IC50: 0.8 nM

++++

ALK2, IC50: 0.8 nM

+++

ALK3, IC50: 5.3 nM

+++

ALK6, IC50: 16.7 nM

99%
LDN-214117 ++

ALK2, IC50: 24 nM

98%
DMH-1 +

ALK2, IC50: 107.9 nM

99%+
SB-505124 +

ALK4, IC50: 129 nM

++

ALK5, IC50: 47 nM

99%+
Vactosertib +++

ALK4, IC50: 13 nM

+++

ALK5, IC50: 11 nM

99%+
Alantolactone 98%
(E/Z)-SIS3 free base 97%
Pirfenidone 98%
Hesperetin 97%
RepSox ++++

TGFβR1(ALK5), IC50: 4 nM

98%
GW788388 +++

ALK5, IC50: 18 nM

98%
LY364947 ++

TGFβRI, IC50: 59 nM

+

TGFβRII, IC50: 0.4 μM

98%
SD-208 ++

TGF-βRI (ALK5), IC50: 48 nM

99%
SB-525334 +++

TGFβR1(ALK5), IC50: 14.3 nM

99%+
LY2109761 ++

TβRI, Ki: 38 nM

+

TβRII, Ki: 300 nM

99%+
Galunisertib ++

TβRI, IC50: 56 nM

98%
SB 431542 +

ALK5, IC50: 94 nM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。
产品名称 CK1 CK2 其他靶点 纯度
PF-670462 2HCl ++++

CK1ε, IC50: 90 nM

CK1δ, IC50: 13 nM

99%+
D4476 ++

CK1δ, IC50: 300 nM

CK1 from Schizosaccharomyces pombe, IC50: 200 nM

99%
SR-3029 +++

CK1ε, IC50: 260 nM

CK1δ, IC50: 44 nM

99%+
IWP-2 +++

M82FCK1δ, IC50: 40 nM

Wnt 99%
LY364947 ++

CK1δ, IC50: 0.22 μM

98%
TA-01 ++++

CK1ε, IC50: 6.4 nM

CK1δ, IC50: 6.8 nM

p38 MAPK 99%+
IC261 +

CK1, IC50: 16 μM

98%
PF-4800567 +++

casein kinase 1 epsilon, IC50: 32 nM

casein kinase 1 delta, IC50: 711 nM

99%+
CK1-IN-1 ++++

CK1ε, IC50: 16 nM

CK1δ, IC50: 15 nM

99%
Longdaysin +

CKIδ, IC50: 8.8 μM

CKIα, IC50: 5.6 μM

99%+
Silmitasertib ++++

CK2, IC50: 1 nM

99%+
Ellagic acid (hydrate) +++

CK2, IC50: 0.04 μM

PKA 95+%
DMAT +++

CK2, Ki: ~40 nM

99%
Hematein ++

CK2, IC50: 0.55 μM

40%
Silmitasertib sodium salt ++++

CK2α', IC50: 1 nM

CK2α, IC50: 1 nM

99%+
LY294002 +++

CK2, IC50: 98 nM

99%+
A-3 HCl +

CK1, Ki: 80 μM

++

CK2, Ki: 5.1 μM

PKC,PKA,MLCK 98+%
TBB +

CK1, Ki: 47 μM

++

CK2, Ki: 0.4 μM

98%
TTP 22 ++

CK2, IC50: 100 nM

98%+
DRB 99%+
BioE-1115 +

CK2α, IC50: 10 μM

99%+
(E/Z)-GO289 ++++

CK2, IC50: 7 nM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

H-89 2HCl 生物活性

靶点
  • PKA

    PKA, Ki:48 nM

描述 PKA is a ubiquitous cellular kinase, also known as cAMP-dependent protein kinase, and it is well-established that plays an important role in regulating several functions of cell processes, including regulation of glycogen, sugar, and lipid metabolism[1]. H-89 2HCl, as a newly synthesized isoquinolinesulfonamide, is a ATP-competitive, potent inhibitor of protein kinase A (PKA)(IC50 = 48 nM), and has weak inhibition on several other kinases with IC50 of 80, 120, 135, 270, 2600 and 2800 nM for S6K1, MSK1, PKA, ROCKII, PKBα and MAPKAP-K1b, respectively[2]. H-89 2HCl has since been used extensively for evaluation of the role of PKA in the heart, osteoblasts, hepatocytes, smooth muscle cells, neuronal tissue, epithelial cells, etc[3]. PC12D cells pretreatment with H-89 2HCl led to a dose-dependent inhibition of the forskolin-induced neurite outgrowth and protein phosphorylation. In vivo experimental method, in skinned EDL fibres of the rat, H-89 2HCl with 1-2 μM significantly slowed the repriming rate in rat skinned fibres. Moreover, rat brain ventricles following an injection with the PKA antagonist, H-89 2HCl, the body temperature is increased further due to the inhibition of TRPV1 phosphorylation[4].
作用机制 H-89 2HCl inhibit the significant modulator role of the cAMP-PKA intracellular signaling pathway mainly acting as a selective and potent inhibitor of protein kinase A (PKA).

H-89 2HCl 细胞实验

Cell Line
Concentration Treated Time Description References
GluTag L-cells 10 μM 30 min inhibited PKA activity, thereby abrogating H-89-induced GLP-1 secretion Mol Nutr Food Res. 2020 Mar;64(6):e1900978.
Sf9 cells 60 µM 1 h H89 2HCl significantly inhibited PKA activity in Sf9 cells and reduced cell tolerance to permethrin. Int J Mol Sci. 2019 Sep 3;20(17):4300.
TF-1 cells 10 μM 1 h Inhibition of PKA activity to study its effect on CREB-1 phosphorylation. Results showed that H-89 significantly inhibited forskolin-induced nuclear accumulation of pCREB-1, indicating that PKA plays a central role in the cAMP-PKA-pCREB network. Biomed Pharmacother. 2011 Jul;65(4):293-7.
TF-1 cells 10 μM 15 h Study the effect of PKA inhibition on CCR5 transcription. Results showed that H-89 significantly inhibited forskolin-induced increase in CCR5 mRNA levels, indicating that PKA acts in concert with CREB to modulate cAMP-mediated CCR5 transcription. Biomed Pharmacother. 2011 Jul;65(4):293-7.
Human Umbilical Vein Endothelial Cells (HUVEC) 20 μM 30 min Inhibited PKA phosphorylation, thereby inhibiting eNOS Ser1177 phosphorylation Cells. 2019 Apr 27;8(5):388.
rat neocortical neurons 10 μM 40 min Inhibition of PKA activity, preventing PTX-induced hyperphosphorylation of Shank3 S1615 Elife. 2022 Apr 26;11:e74277.
COX-2 KO and control cells 10 µM 6 days To study the role of H-89 in COX-2 KO and control cells, it was found that H-89 attenuated the suppressing effect of PGE2 on adipocyte differentiation. Cells. 2022 Jun 2;11(11):1819.
bone marrow-derived macrophages (BMDMs) 20 μM 1 h To investigate whether db-cAMP-induced macrophage polarization is dependent on PKA.The results showed that pre-treatment with H89 inhibited db-cAMP-induced Arg-1 and CD206 expression and IL-10 levels, suggesting that PKA is involved in db-cAMP-induced macrophage polarization Cells. 2020 Jan 6;9(1):128.

H-89 2HCl 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Culex quinquefasciatus HAmCqG8 and MAmCqG6 resistant mosquito larvae Water treatment 6.25, 12.5, 25, 50 µM Single treatment, lasting 24 hours H89 2HCl significantly reduced the resistance of mosquito larvae to permethrin. Int J Mol Sci. 2019 Sep 3;20(17):4300.
BALB/c mice LPS-induced pleurisy model Intrapleural injection 4 mg/kg Single injection, lasting 30 hours To investigate the effect of db-cAMP on macrophage polarization in vivo, results showed that db-cAMP decreased the number of LPS-induced M1 macrophages and increased the expression of engulfment-related molecules AnxA1 and CD36. Cells. 2020 Jan 6;9(1):128.
Mice Acute brain slices Intraperitoneal or subcutaneous injections 5 mg/kg Single injection, lasting 30 minutes H-89 pretreatment prevented the increase in mEPSC frequency and dendritic spine density induced by Drd1 agonist Elife. 2015 Nov 9;4:e10111
Mice High-fat diet-induced MAFL model Intraperitoneal injection 1 mg/kg Once daily for 8 weeks To evaluate the effect of H-89 on MAFL formation, the results showed that H-89 significantly improved hepatic steatosis and reduced ALT activity, and decreased the nuclear level of mature SREBP1c. Cell Rep Med. 2024 Mar 19;5(3):101477

H-89 2HCl 动物研究

Dose Mice: 0.05 mg/kg - 5 mg/kg[5] (i.p.) Rat: 20 mg/kg - 200 mg/kg[6] (s.c.)
Administration i.p., s.c.
Pharmacokinetics
Animal Rats[6]
Dose 20 mg/kg
Administration s.c.
MRT 6.84 h
AUC0-inf 6951.06 ng/h/ml
T1/2 6.78 h
Tmax 4 h
Cmax 436 ng/ml
AUC 6489.99 ng/h/ml

H-89 2HCl 参考文献

[1]Dolan S, Nolan AM. Biphasic modulation of nociceptive processing by the cyclic AMP-protein kinase A signalling pathway in sheep spinal cord. Neurosci Lett. 2001;309(3):157-60.

[2]Chijiwa T, Mishima A, et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem. 1990;265(9):5267-72.

[3]Lochner A, Moolman JA. The many faces of H89: a review. Cardiovasc Drug Rev. 2006;24(3-4):261-74.

[4]Bao D, Zhao W, et al. H89 dihydrochloride hydrate and calphostin C lower the body temperature through TRPV1. Mol Med Rep. 2018;17(1):1599-1608.

[5]Seyedi SY, Salehi F, et al. Dual effect of cAMP agonist on ameliorative function of PKA inhibitor in morphine-dependent mice. Fundam Clin Pharmacol. 2014 Aug;28(4):445-54.

[6]Davis MA, Hinerfeld D, et al. Proteomic analysis of rat liver phosphoproteins after treatment with protein kinase inhibitor H89 (N-(2-[p-bromocinnamylamino-]ethyl)-5-isoquinolinesulfonamide). J Pharmacol Exp Ther. 2006 Aug;318(2):589-95. Epub 2006 May 10.

H-89 2HCl 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.93mL

0.39mL

0.19mL

9.63mL

1.93mL

0.96mL

19.26mL

3.85mL

1.93mL

H-89 2HCl 技术信息

CAS号130964-39-5
分子式C20H22BrCl2N3O2S
分子量 519.28
SMILES Code O=S(C1=CC=CC2=C1C=CN=C2)(NCCNC/C=C/C3=CC=C(Br)C=C3)=O.[H]Cl.[H]Cl
MDL No. MFCD00214120
别名 H-89 (hydrochloride); Protein Kinase Inhibitor H-89; 5-Isoquinolinesulfonamide; H-89 dihydrochloride
运输蓝冰
InChI Key GELOGQJVGPIKAM-WTVBWJGASA-N
Pubchem ID 5702541
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 105 mg/mL(202.2 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 5 mg/mL(9.63 mM),配合低频超声,并水浴加热至45℃助溶

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
方案 四
方案 五
方案 六
方案 七
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。